Abstract:BACKGROUND:Growing evidence indicates that endometriosis is an epigenetic disease. Encouragingly, histone deacetylases (HDACs) and DNA methyltransferases have been shown to be promising targets by numerous in vitro studies. However, only a few studies have shown promising effects of HDAC inhibition in preclinical studies in endometriosis. While lysine-specific demethylase 1 (LSD1) is recently found to be aberrantly expressed in endometriosis, and that the treatment of endometriotic stromal cells with tranylcypromine (TC), an LSD1 inhibitor, significantly reduced cellular proliferation, cell cycle progression, and invasiveness, the in vivo effect of TC treatment is currently lacking. This study sought to evaluate the effect of TC in a mouse model of endometriosis.METHODS:Forty-seven female C57BL/6 mice were used in this experimentation. All mice, except those randomly selected to form Sham surgery (M) and specificity control (S) groups, received an endometriosis-inducing surgery. Group S was set up mainly to ensure that the reduced generalized hyperalgesia in mice treated with TC is not due to any possible analgesic effect of TC, but rather resulting from the treatment effect specific to endometriosis. Two weeks after the surgery, mice that received surgery were further divided randomly into 3 groups: 1) untreated group (U); 2) low-dose TC group (L); 3) high-dose TC group (H). Group S received the same treatment as in group H. Two weeks after treatment, all mice were sacrificed and their ectopic endometrial tissues were harvested and analyzed by immunohistochemistry analysis. Hotplate test was administrated to all mice before the induction, treatment and sacrifice. Lesion size, hotplate latency, immunoreactivity against markers of proliferation, angiogenesis, H3K4 methylation, and of epithelial-mesenchymal transition (EMT).RESULTS:TC treatment significantly and substantially reduced the lesion size and improved generalized hyperalgesia in a dose-dependent fashion in mice with induced endometriosis. In addition, TC treatment resulted in reduced immunoreactivity to biomarkers of proliferation, angiogenesis, and H3K4 methylation, leading to arrested EMT and lesion growth.CONCLUSION:In light of our previously reported reduced cellular proliferation, cell cycle progression and invasiveness resulting from the LSD1 inhibition in in vitro studies, our data strongly suggest that LSD1 is a promising therapeutic target for endometriosis.TRIAL REGISTRATION:Not applicable.

Suppression of IL-1beta-induced COX-2 expression by trichostatin A (TSA) in human endometrial stromal cells.

Histone Deacetylase Inhibitors Trichostatin A and Valproic Acid Induce Cell Cycle Arrest and P21 Expression in Immortalized Human Endometrial Stromal Cells.

Trichostatin A, a Histone Deacetylase Inhibitor, Attenuates Invasiveness and Reactivates E-Cadherin Expression in Immortalized Endometriotic Cells

Peroxisome proliferator-activated receptor-gamma and retinoid X receptor agonists synergistically suppress proliferation of immortalized endometrial stromal cells.

Constitutive and Tumor Necrosis Factor-Alpha-stimulated Activation of Nuclear Factor-Kappab in Immortalized Endometriotic Cells and Their Suppression by Trichostatin A.

Effects of trichostatin A on the expressions of inflammatory cytokines and toll-like receptor 4 and the acetylation of nuclear factor-κB induced by lipopolysaccharide in macrophage

Trichostatin A, A Histone Deacetylase Inhibitor, Reduces Lesion Growth and Hyperalgesia in Experimentally Induced Endometriosis in Mice

Autocrine Production of Interleukin-34 Promotes the Development of Endometriosis Through CSF1R/JAK3/STAT6 Signaling

MAPK/ERK signal pathway involved expression of COX-2 and VEGF by IL-1β induced in human endometriosis stromal cells in vitro

Inhibition Of Proliferation Of Endometrial Stromal Cells By Trichostatin A, Ru486, Cdb-2914, N-Acetylcysteine, And Ici 182780

Trichostatin A Increases the TIMP-1/MMP Ratio to Protect Against Osteoarthritis in an Animal Model of the Disease.

Celecoxib attenuates interleukin 33-induced expression of vascular cell adhesion molecule-1 in human ovarian endometriotic stromal cells

Proteomics reveals protein profile changes in cyclooxygenase-2 inhibitor-treated endometrial cancer cells

Pyrvinium pamoate induces in-vitro suppression of IL-6 and IL-8 produced by human endometriotic stromal cells

Inhibition of EGFR/PI3K/AKT Cell Survival Pathway Promotes TSA's Effect on Cell Death and Migration in Human Ovarian Cancer Cells.

A Small-Molecule Triptolide Regulates Survival and Migration of Stromal Cells from Patients with Endometriosis

Progesterone and estradiol alleviate Poly I:C-induced immune response in endometrial stromal cells

Effect of Trichostatin A on proliferation and migration of vascular smooth muscle cells

Tranylcypromine, a Lysine-Specific Demethylase 1 (LSD1) Inhibitor, Suppresses Lesion Growth and Improves Generalized Hyperalgesia in Mouse with Induced Endometriosis.

Cyclooxygenase-2 In Endometriosis

Effects of combined 17beta-estradiol with TCDD on secretion of chemokine IL-8 and expression of its receptor CXCR1 in endometriotic focus-associated cells in co-culture.